Purpose This study aimed to explore the incidence and severity of vincristine-induced
peripheral neuropathy (VIPN) in non-Hodgkin lymphoma (NHL) survivors (primary aim) and …

Objective The present study examined the objective and patient-reported measures of
physical impairments, sensory disturbance, and functional ability between cancer patients …

Background The objective of this study was to systematically review all available literature
concerning chemotherapy-induced peripheral neuropathy (CIPN) and quality of life (QOL) …

Purpose Vincristine (VCR) is a chemotherapeutic agent used in the treatment of pediatric
oncology patients, but its main toxicity is VCR‐induced peripheral neuropathy (VIPN) …

Background Decades following the introduction of vincristine as treatment for
haematological malignancies, vincristine-induced peripheral neuropathy (VIPN) remains a …

Purpose A significant side effect of cancer treatment is chemotherapy-induced peripheral
neurotoxicity (CIPN). CIPN can have a serious negative impact on the patient's quality of life …

Background Appropriate assessment is essential for the management of chemotherapy-
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …

Purpose Chemotherapy-induced peripheral neuropathy is a common treatment-related
adverse effect. It adversely affects the quality of life. Therefore, it is important to evaluate …

Purpose A significant proportion of cancer patients suffer from chemotherapy-induced
peripheral neuropathy (CIPN). This descriptive study aimed to examine patients' experience …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of
neurotoxic anticancer drugs that may affect quality of life (QoL). Purpose: The purposes of …